Copyright: ©Author(s) 2026.
World J Gastroenterol. Sep 7, 2026; 32(33): 118185
Published online Sep 7, 2026. doi: 10.3748/wjg.118185
Published online Sep 7, 2026. doi: 10.3748/wjg.118185
Table 1 Clinical characteristics of the study participants
| Characteristics | Healthy control (n = 47) | BGD (n = 57) | GC (n = 42) | CRC (n = 63) |
| Age (median, range) | 48.0 (36.5-61.0) | 55.0 (44.0-65.0) | 58.5 (49.5-65.8)a | 63.0 (55.0-68.0)a |
| Gender (female/male) | 28/19 | 27/30 | 14/28a | 25/38 |
| TNM stage | ||||
| I + II | - | - | 14 | 30 |
| III + IV | - | - | 28 | 33 |
| CEA (ng/mL) | 1.16 (0.92-1.64) | 1.85 (1.30-2.90) | 2.49 (1.42-7.82)a | 5.04 (2.60-11.80)a |
| CA199 (U/mL) | 2.04 (0.81-6.31) | 12.11 (7.73-18.47) | 14.28 (8.97-24.65)a | 14.64 (6.48-99.55)a |
| Creatinine (μmol/L) | 4314 (2647-8531) | 9611 (5299-14520) | 6672 (3691-11540)a | 6042 (3257-12250)a |
| DiAcSpm (μmol/g· Cre) | 0.58 (0.47-0.79) | 0.56 (0.41-0.85) | 0.82 (0.61-1.25)a | 0.83 (0.56-1.35)a |
Table 2 The relationship between urinary N1, N12-diacetylspermine and clinical features in patients with gastric cancer and those with colorectal cancer, n (%)
| Clinical features | GC | CRC | ||||
| Low (n = 21)1 | High (n = 21)1 | P value | Low (n = 32)1 | High (n = 31)1 | P value | |
| Age | 0.756 | - | 0.799 | |||
| ≤ 60 | 13 (61.9) | 11 (52.4) | 12 (37.5) | 13 (41.9) | ||
| > 60 | 8 (38.1) | 10 (47.6) | 20 (62.5) | 18 (58.1) | ||
| Gender | 0.744 | - | 0.074 | |||
| Male | 15 (71.4) | 13 (61.9) | 23 (71.9) | 15 (48.4) | ||
| Female | 6 (28.6) | 8 (38.1) | 9 (28.1) | 16 (51.6) | ||
| CEA (ng/mL) | 1.000 | - | 0.133 | |||
| ≤ 5 | 13 (61.9) | 13 (61.9) | 19 (59.4) | 12 (38.7) | ||
| > 5 | 8 (38.1) | 8 (38.1) | 13 (40.6) | 19 (61.3) | ||
| CA199 (U/mL) | 0.663 | - | 0.788 | |||
| ≤ 43 | 17 (81.0) | 19 (90.5) | 23 (71.9) | 21 (67.7) | ||
| > 43 | 4 (19.0) | 2 (9.5) | 9 (28.1) | 10 (32.3) | ||
| TNM stage | 0.326 | - | 0.453 | |||
| I + II | 9 (42.9) | 5 (23.8) | 17 (53.1) | 13 (41.9) | ||
| III + IV | 12 (57.1) | 16 (76.2) | 15 (46.9) | 18 (58.1) | ||
| Lymph node metastasis | 0.505 | - | 0.617 | |||
| Yes | 13 (61.9) | 16 (76.2) | 15 (46.9) | 17 (54.8) | ||
| No | 8 (38.1) | 5 (23.8) | 17 (53.1) | 14 (45.2) | ||
| Distant metastasis | 0.028 | - | 0.064 | |||
| Yes | 5 (23.8) | 13 (61.9) | 7 (21.9) | 14 (45.2) | ||
| No | 16 (76.2) | 8 (38.1) | 25 (78.1) | 17 (54.8) | ||
| Differentiation degrees | 0.136 | - | 0.185 | |||
| Well | 2 (9.5) | 1 (4.8) | 4 (12.5) | 2 (6.5) | ||
| Moderate | 8 (38.1) | 3 (14.3) | 25 (78.1) | 21 (67.7) | ||
| Poor | 11 (52.4) | 17 (80.9) | 3 (9.4) | 8 (25.8) | ||
- Citation: Zheng HZ, Wang P, Zheng HJ, Wang ZQ, Li QX, Chen HW, Chen HQ, Lei QC. Urinary N1, N12-diacetylspermine as a potential tumor biomarker for gastric and colorectal cancer. World J Gastroenterol 2026; 32(33): 118185
- URL: https://www.wjgnet.com/1007-9327/full/v32/i33/118185.htm
- DOI: https://dx.doi.org/10.3748/wjg.118185